ストックスクリーナーアプリを入手
28.17
0.21%
0.06
アフターアワーズ：
28.17
前日終値:
$28.11
開ける：
$28.24
24時間の取引高:
341.54K
Relative Volume:
1.01
時価総額：
$1.05B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.38%
1か月 パフォーマンス:
+46.49%
6か月 パフォーマンス:
+169.83%
1年 パフォーマンス:
+0.61%
1日の値動き範囲:
$27.45
$28.98
1週間の範囲:
$27.10
$29.46
52週間の値動き範囲:
$5.485
$29.46
Oruka Therapeutics Inc Stock (ORKA) Company Profile
ORKA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
28.17 | 1.36B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-27 | 開始されました | Guggenheim | Buy |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-05-22 | 開始されました | BTIG Research | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-10-11 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-17 | 開始されました | Leerink Partners | Outperform |
| 2024-09-16 | 開始されました | TD Cowen | Buy |
| 2024-09-13 | 開始されました | Jefferies | Buy |
| 2018-02-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 開始されました | Dawson James | Buy |
すべてを表示
Oruka Therapeutics Inc (ORKA) 最新ニュース
Is Oruka Therapeutics Inc. (HQ1) stock undervalued at current price2025 Top Decliners & Safe Swing Trade Setups - newser.com
Is Oruka Therapeutics Inc. stock supported by strong cash flowsTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Will Oruka Therapeutics Inc. stock outperform growth indexes2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Can Oruka Therapeutics Inc. (HQ1) stock hold up in economic slowdownJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
What analysts say about Oruka Therapeutics Inc stockCovered Call Writing & Control Your Emotions With Discipline Tools - earlytimes.in
Why Oruka Therapeutics Inc. stock attracts global investorsEarnings Growth Report & Free Fast Gain Swing Trade Alerts - newser.com
What technical patterns form on Oruka Therapeutics Inc. (HQ1) stock chartsWeekly Trend Report & Low Drawdown Investment Strategies - newser.com
Will Oruka Therapeutics Inc. stock recover faster than marketTrade Volume Summary & High Accuracy Investment Signals - newser.com
Will Oruka Therapeutics Inc. (HQ1) stock return to pre crash levelsJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Published on: 2025-10-31 04:52:14 - newser.com
Price action breakdown for Oruka Therapeutics Inc.Insider Buying & Verified Entry Point Detection - newser.com
Volume spikes in Oruka Therapeutics Inc. stock – what they meanChart Signals & Consistent Profit Alerts - newser.com
Pattern recognition hints at Oruka Therapeutics Inc. upside2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Why retail investors favor Oruka Therapeutics Inc. stock2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Will Oruka Therapeutics Inc. stock go up soonGap Down & Entry and Exit Point Strategies - newser.com
HC Wainwright Brokers Raise Earnings Estimates for ORKA - MarketBeat
Key metrics from Oruka Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
Is Oruka Therapeutics Inc. stock a bargain at current levels2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Q3 EPS Forecast for Oruka Therapeutics Boosted by Analyst - Defense World
Published on: 2025-10-29 21:32:46 - newser.com
Wall Street Analysts Predict a 63.59% Upside in Oruka Therapeutics, Inc. (ORKA): Here's What You Should Know - sharewise.com
Oruka Therapeutics to Present at Multiple November Investor Conferences - The Manila Times
Oruka Therapeutics (NASDAQ:ORKA) Now Covered by Analysts at Guggenheim - Defense World
Oruka Therapeutics’ Promising Psoriasis Study: What Investors Need to Know - TipRanks
Oruka Therapeutics Inc (ORKA) 財務データ
Oruka Therapeutics Inc (ORKA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):